Women’s health could benefit from the private equity treatment

Read article at FT.com

Private equity firms are rarely credited with helping to cure societal ills. But sometimes, as in the case of Blackstone and TPG’s $18bn purchase of medical technology group Hologic, buyout shops have a chance to do good and do well at the same time. Hologic is focused on women’s health, providing devices for cervical and breast cancer screening, as well as uterine health. Women generally are an underserved market, tending to receive less effective treatments and poorer care than male patients. Eliminating the gap could be worth $1tn to the global economy by 2040, McKinsey and the World Economic Forum estimated last year, much of it through recovering the seven days the average woman loses per year to ill health… Read article at FT.com